Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 152Breast Neoplasms 40Prostatic Neoplasms 31Insulin Resistance 30Obesity 23Neoplasms 15Endometrial Neoplasms 15Pancreatic Neoplasms 14Infertility 14Colorectal Neoplasms 13Carcinoma, Non-Small-Cell Lung 12Anovulation 10Lung Neoplasms 9Neoplasm Metastasis 8Hyperandrogenism 8Glioblastoma 8Diabetes Mellitus 8Squamous Cell Carcinoma of Head and Neck 7Metabolic Syndrome 7Melanoma 7Rectal Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Ovarian Neoplasms 5Lymphoma, Large B-Cell, Diffuse 5Head and Neck Neoplasms 5Brain Neoplasms 5Adenocarcinoma 5Weight Loss 4Uterine Cervical Neoplasms 4Urinary Bladder Neoplasms 4

Interventions

Specimen Handling 1Physical Examination 1Metformin 1Mastectomy, Subcutaneous 1Mastectomy 1Diffusion Magnetic Resonance Imaging 1Colonoscopy 1Arsenic Trioxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Li-Fraumeni Syndrome × Metformin × Clear all
NCT01981525 2020-12-14

A Pilot Study of Metformin in Patients With a Diagnosis of Li-Fraumeni Syndrome

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
26 enrolled

Li-Fraumeni Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡